Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$0.46 - $0.81 $4,876 - $8,586
10,600 New
10,600 $5,000
Q4 2022

Feb 14, 2023

SELL
$0.29 - $0.47 $3,277 - $5,311
-11,300 Reduced 44.14%
14,300 $0
Q3 2022

Nov 14, 2022

SELL
$0.38 - $0.73 $3,990 - $7,665
-10,500 Reduced 29.09%
25,600 $0
Q2 2022

Aug 12, 2022

BUY
$0.37 - $0.61 $3,441 - $5,673
9,300 Added 34.7%
36,100 $1,000
Q1 2022

May 12, 2022

BUY
$0.53 - $1.19 $4,240 - $9,520
8,000 Added 42.55%
26,800 $1,000
Q4 2021

Feb 14, 2022

SELL
$1.03 - $2.31 $18,540 - $41,580
-18,000 Reduced 48.91%
18,800 $3,000
Q3 2021

Nov 10, 2021

SELL
$1.74 - $2.93 $25,578 - $43,071
-14,700 Reduced 28.54%
36,800 $9,000
Q2 2021

Aug 11, 2021

SELL
$1.52 - $3.62 $8,208 - $19,548
-5,400 Reduced 9.49%
51,500 $33,000
Q1 2021

May 14, 2021

BUY
$0.9 - $6.32 $51,210 - $359,608
56,900 New
56,900 $69,000

Others Institutions Holding ASXC

About ASENSUS SURGICAL, INC.


  • Ticker ASXC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 236,719,008
  • Market Cap $82.9M
  • Description
  • Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical int...
More about ASXC
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.